5th World Congress on
Addiction Medicine and Psychiatry

Addiction neuroscience is an interdisciplinary field that explores the neurobiological mechanisms underlying addiction. It investigates how the brain processes reward, motivation, and decision-making, shedding light on the biological aspects of addiction development and providing insights for potential treatments and prevention strategies. Recent research at the crossroads of addiction and neuroscience has unveiled breakthroughs in understanding how specific brain circuits and neurotransmitters contribute to addictive behaviors. These findings hold promise for the development of more targeted interventions and medications to combat addiction. Cutting-edge neuroimaging techniques have further advanced our knowledge of the neural changes associated with addiction, shedding light on potential therapeutic avenues. This session is designed to delve into crucial aspects at the intersection of addiction and neuroscience.

• Track 2-1  Neurobiological Basis of Addiction
• Track 2-2  Neuroplasticity and Addiction
• Track 2-3  Neuroimaging and Addiction Research
• Track 2-4  Neurotransmitters and Addiction
• Track 2-5  Stress and Addiction

Alcohol addiction, or alcoholism, is a chronic and potentially severe condition characterized by the compulsive consumption of alcohol, despite adverse consequences and a loss of control over drinking. It often leads to physical and psychological dependence, impacting both the individual's health and their social and occupational functioning. Recent research in alcohol addiction has uncovered new findings on the genetic and neurobiological factors contributing to alcohol dependence. Studies have highlighted the potential benefits of personalized treatment approaches, leveraging genetic markers, to improve the effectiveness of interventions. Additionally, emerging pharmaceutical interventions and digital health tools are being investigated to enhance recovery outcomes for individuals with alcohol use disorder. This session is planned to cover various essential aspects within the domain of alcohol addiction and its treatment.

• Track 3-1  Alcohol Withdrawal and Detoxification
• Track 3-2  Alcohol Use Disorder Treatment
• Track 3-3  Co-occurring Mental Health Disorders
• Track 3-4  Alcohol and Brain Health
• Track 3-5  Prevention and Harm Reduction

Food addiction is a complex and controversial concept that suggests certain individuals may exhibit addictive behaviors and cravings related to specific foods, often high in sugar, fat, or salt. While not officially recognized as a mental disorder, some research explores the neurological and psychological mechanisms behind this phenomenon and its potential impact on public health. Recent research on food addiction has revealed the impact of highly processed and hyper-palatable foods on brain circuits associated with reward and craving, providing insights into the mechanisms that drive overeating. Furthermore, investigations into the gut-brain connection have highlighted the role of the microbiome in regulating appetite and food preferences, potentially contributing to the development of food addiction. Behavioral and cognitive studies are also focusing on innovative interventions and therapies to address this complex issue and promote healthier eating habits. This session aims to delve into various critical aspects related to food addiction and its impact.

• Track 4-1  Neurobiology of Food Addiction
• Track 4-2  Emotional Eating and Food Addiction
• Track 4-3  Treatment Approaches for Food Addiction
• Track 4-4  Food Cravings and Brain Chemistry
• Track 4-5  Impact of Food Advertising and Environment

Social media addiction describes the compulsive and harmful overconsumption of social platforms, often resulting in negative impacts on mental health and relationships, underscoring the importance of addressing this modern behavioral issue. Recent studies on social media addiction have emphasized the psychological and emotional toll it takes on individuals, with findings highlighting its association with anxiety, depression, and decreased well-being. Additionally, research has explored the influence of algorithms and notifications on perpetuating addictive social media use, suggesting potential strategies for mitigating this issue. The development of digital well-being tools and interventions has gained traction as a means to counteract the negative consequences of excessive social media engagement. This session is intended to investigate various significant dimensions of social media addiction and its implications.

• Track 5-1  Effects on Mental Health
• Track 5-2  Social Media Withdrawal
• Track 5-3  Treatment and Intervention
• Track 5-4  Psychological Factors
• Track 5-5  Parenting and Youth

Alcoholism and drug addiction are chronic, complex conditions characterized by a compulsive and harmful pattern of substance use, often leading to severe physical, psychological, and social consequences. Treatment approaches for these disorders typically involve a combination of behavioral therapies, medication-assisted treatment, and support to help individuals achieve and maintain recovery. Recent research in the field of alcoholism and drug addiction has revealed promising developments, including the effectiveness of innovative medications in reducing cravings and preventing relapse. Furthermore, studies have underscored the importance of personalized treatment strategies, tailoring interventions to individual needs. Advances in neuroimaging have deepened our understanding of the neural mechanisms underlying addictive behaviors, offering potential insights for more targeted interventions. This session is planned to address essential facets related to substance use disorders and their management.

• Track 6-1  Detoxification and Withdrawal
• Track 6-2  Treatment Modalities
• Track 6-3  Relapse Prevention
• Track 6-4  Harm Reduction Strategies
• Track 6-5  Stigma and Addiction

Drug addiction and abuse represent a complex and pressing public health concern, characterized by the compulsive use of substances despite adverse consequences, often requiring comprehensive treatment and support for recovery. Prevention, early intervention, and access to evidence-based treatments are crucial in addressing this global issue. Recent research in addiction medicine has focused on the development of more targeted and effective medications to combat substance use disorders, emphasizing the importance of personalized treatment approaches. Studies also highlight the role of behavioral interventions and support systems in promoting long-term recovery. Furthermore, advancements in telehealth and digital therapeutics have expanded access to addiction treatment, improving patient outcomes and increasing the reach of addiction services. This session is planned to examine a variety of pertinent topics within the field of addiction and substance abuse.

• Track 7-1  Types of Substances
• Track 7-2  Risk Factors and Vulnerability
• Track 7-3  Harm Reduction Strategies
• Track 7-4  Pharmacological Treatments
• Track 7-5  Community-Based Interventions

Psychopharmacology plays a pivotal role in addiction treatment by utilizing medications to target the neurological mechanisms of addiction, aiding individuals in managing cravings and withdrawal symptoms. It's a crucial component of comprehensive addiction care, often used in conjunction with behavioral therapies for more effective outcomes. Recent research in the realm of psychopharmacology for addiction treatment has revealed innovative medications that show promise in reducing the severity of withdrawal symptoms and curbing cravings in individuals with substance use disorders. Additionally, studies have emphasized the need for personalized medication approaches, recognizing that individuals may respond differently to various pharmacological treatments. Furthermore, ongoing research explores the potential of combining psychopharmacological interventions with behavioral therapies to enhance the overall effectiveness of addiction treatment. This session will conduct an in-depth exploration of various critical aspects within the field of psychopharmacology in addiction treatment.

• Track 8-1  Medication-Assisted Treatment (MAT)
• Track 8-2  Opioid Agonist Therapy
• Track 8-3  Anti-Craving Medications
• Track 8-4  Dual Diagnosis and Psychopharmacology
• Track 8-5  Long-Term Medication Management

Addiction and co-occurring mood disorders are often interconnected and can significantly impact an individual's physical, emotional, and psychological well-being. Co-occurring mood disorders, such as depression, anxiety, bipolar disorder, or other mood-related conditions, frequently coexist with addiction, creating a complex and challenging clinical situation. Recent research in the field of addiction and co-occurring mood disorders suggests that integrated treatment approaches, combining psychotherapy and medication when appropriate, show promising results in improving outcomes for individuals facing this dual diagnosis. Furthermore, studies emphasize the importance of early intervention and personalized treatment plans to address the unique needs of each patient, ultimately enhancing their chances of sustained recovery and improved mental health. These findings underscore the ongoing effort to develop more effective strategies for managing this complex and prevalent comorbidity. This session will delve into the complex interaction between addiction and co-occurring mood disorders, with a focus on comprehensive treatment strategies that address both conditions concurrently.

• Track 9-1  Understanding Co-Occurring Disorders
• Track 9-2  Impact of Addiction on Mood Disorders
• Track 9-3  Impact of Mood Disorders on Addiction
• Track 9-4  Treatment Approaches for Co-Occurring Disorders
• Track 9-5  Recovery and Relapse Prevention

Addiction medicine is a specialized field designed to equip healthcare professionals with the knowledge and skills to diagnose and treat substance use disorders effectively. It plays a crucial role in improving patient care by addressing the complex and prevalent issue of addiction. Recent research in addiction medicine has highlighted the effectiveness of telehealth and digital platforms in providing accessible and evidence-based care for individuals with substance use disorders, particularly during challenging times like the COVID-19 pandemic. Moreover, studies emphasize the importance of integrating addiction treatment into primary care settings, ensuring that individuals receive comprehensive healthcare that addresses both physical and behavioral health concerns. This session is planned to equip healthcare professionals with essential knowledge and skills in addiction medicine, enabling them to effectively diagnose and treat substance use disorders, with a focus on best practices.

• Track 10-1  Pharmacological Treatments
• Track 10-2  Behavioral Interventions and Therapy
• Track 10-3  Co-Occurring Disorders
• Track 10-4  Relapse Prevention and Recovery Support
• Track 10-5  Harm Reduction and Public Health Approaches

Addiction psychiatry plays a pivotal role in addressing the opioid crisis, as it focuses on both the treatment of opioid use disorders and the development of harm-reduction strategies. By integrating clinical expertise and research, addiction psychiatrists contribute to the multidisciplinary efforts needed to combat this public health emergency. Recent research in addiction psychiatry underscores the effectiveness of medication-assisted treatment (MAT) in reducing opioid cravings and overdose risk, highlighting its significance in combating the opioid crisis. Furthermore, studies emphasize the role of telehealth interventions for opioid use disorder, offering accessible treatment options and support to individuals in underserved areas. Additionally, investigations into the impact of fentanyl and its analogs reveal the urgency of novel prevention and harm-reduction strategies to address this rapidly evolving facet of the crisis. This session will discuss addiction psychiatry and its connection to the opioid crisis.

• Track 11-1  Opioid Epidemic Overview
• Track 11-2  Neurobiology of Opioid Addiction
• Track 11-3  Pharmacological Interventions
• Track 11-4  Psychosocial Interventions
• Track 11-5  Integrated Care and Co-Occurring Disorders

The neurobiology of addiction and mental illness involves intricate interactions within the brain's neural circuits, affecting behavior and emotional regulation. Understanding these underlying mechanisms is crucial for developing effective interventions and treatments for individuals with co-occurring conditions. Recent research in the field of the neurobiology of addiction and mental illness has been focused on identifying the specific neurochemical and genetic factors that contribute to the overlap between these conditions. This research aims to develop targeted therapies that address the underlying neurobiological mechanisms and improve outcomes for individuals with co-occurring addiction and mental health disorders. This session will explore the latest research in the neurobiology of addiction and mental illness, highlighting potential advancements in treatment.

• Track 12-1  Neuroplasticity and Habit Formation
• Track 12-2  The Role of Stress and the HPA Axis
• Track 12-3  Neuroinflammation
• Track 12-4  Neurocircuitry and Cognitive Impairments
• Track 12-5  Neurobiology of Craving and Relapse

Individuals with personality disorders are at an increased risk of developing addiction, as these conditions can lead to maladaptive coping strategies. Understanding the connection between these disorders is crucial for providing effective and holistic treatment. Recent research at the intersection of personality disorders and addiction has shed light on the complex relationship between the two. Studies have emphasized the importance of early intervention and integrated treatments, highlighting the need for tailored approaches to address both conditions concurrently. Additionally, research has explored the underlying psychological and neurological mechanisms, offering insights into the development of more effective interventions for individuals with co-occurring personality disorders and addiction. This session will explore the interplay between Personality Disorders and Addiction, addressing treatment approaches, recovery, and long-term management.

• Track 13-1  Co-Occurrence of Personality Disorders and Addiction
• Track 13-2  Personality Disorder Subtypes and Addictive Behaviors
• Track 13-3  Impact on Treatment Approaches
• Track 13-4  Self-Medication and Coping Mechanisms
• Track 13-5  Recovery and Long-Term Management

Child and Adolescent Addiction Psychiatry focuses on the specialized field of diagnosing and treating substance use disorders in young individuals, tailoring interventions to their unique developmental needs. It encompasses a wide range of strategies and therapies aimed at promoting recovery and preventing long-term addiction-related issues in the pediatric and adolescent populations. Recent research in Child and Adolescent Addiction Psychiatry has highlighted the significance of early intervention and prevention strategies to address substance use disorders in this vulnerable population. Additionally, advancements in technology, such as telehealth and mobile apps, have shown promise in enhancing accessibility and engagement in addiction treatment for children and adolescents. This session on Child and Adolescent Addiction Psychiatry will focus on addressing substance use challenges in youth and effective treatment strategies, including the crucial role of family support.

• Track 14-1  Co-Occurring Disorders and Dual Diagnosis
• Track 14-2  Pharmacotherapy for Youth
• Track 14-3  Cultural Sensitivity and Diversity
• Track 14-4  Legal and Ethical Considerations
• Track 14-5  Transition to Adult Care

Alcohol Use Disorders often co-occur with various comorbid conditions, such as anxiety, depression, and other substance use disorders, making integrated treatment approaches vital for comprehensive care and recovery. Understanding and addressing these concurrent conditions is essential for a holistic and successful treatment of alcohol addiction. Recent research in Alcohol Use Disorders and Comorbid Conditions has shown promising developments in identifying genetic, neurobiological, and environmental factors contributing to the co-occurrence of alcohol addiction and mental health issues. Additionally, studies emphasize the effectiveness of integrated treatment models that address both alcohol use and comorbid conditions simultaneously, improving long-term outcomes. This session will provide a deep exploration of the connections between alcohol addiction and concurrent mental health challenges, addressing their complexities and integrated treatment solutions.

• Track 15-1  Co-Occurring Mental Health Disorders
• Track 15-2  Physical Health Consequences
• Track 15-3  Dual Diagnosis Assessment and Diagnosis
• Track 15-4  Integrated Treatment Approaches
• Track 15-5  Support and Relapse Prevention

Anxiety disorders often intersect with substance use, as individuals may use substances to alleviate their anxiety symptoms, leading to a complex cycle of dependence. Understanding this connection is crucial for developing effective interventions and support strategies. Recent research in Anxiety Disorders and Substance Use has highlighted the bidirectional relationship between these conditions, demonstrating that anxiety can increase the risk of substance use and vice versa. Moreover, studies have explored the role of integrated treatments, including cognitive-behavioral therapy and pharmacological interventions, in addressing both anxiety and substance use simultaneously. Innovative research also focuses on digital mental health tools and teletherapy to enhance accessibility and engagement in treatment for individuals dealing with these dual challenges. This session will address the complex interconnection between psychological distress and substance misuse, focusing on holistic treatment strategies.

• Track 16-1  Prevalence and Correlation
• Track 16-2  Self-Medication Hypothesis
• Track 16-3  Impact on Treatment
• Track 16-4  Pharmacological Interventions
• Track 16-5  Cognitive-Behavioral Interventions

Eating disorders often co-occur with substance abuse, as individuals may turn to drugs or alcohol as coping mechanisms or to control weight. Understanding this dual challenge is essential for providing effective support and treatment for affected individuals. Recent research in the field of Eating Disorders and Substance Abuse highlights the bidirectional relationship between these conditions, with substance use potentially triggering or exacerbating eating disorders, and vice versa. Studies have also explored innovative treatment approaches, such as dialectical behavior therapy and integrated care models, to address both issues concurrently, improving overall outcomes. Additionally, advancements in technology, like mobile apps and telehealth services, show promise in providing accessible and engaging support for individuals dealing with these co-occurring challenges. This session will comprehensively explore the intersection of Eating Disorders and Substance Abuse, addressing the intertwined challenges and integrated treatment strategies.

• Track 17-1  Comorbidity of Eating Disorders and Substance Abuse
• Track 17-2  Self-Medication and Coping Mechanisms in Co-Occurrence
• Track 17-3  Consequences for Physical and Mental Health
• Track 17-4  Diagnosis Challenges in Dual Disorders
• Track 17-5  Integrated Treatment Approaches for Co-Occurring Conditions

Addiction Psychiatry plays a vital role in the intersection with the criminal justice system, providing specialized assessment and treatment for individuals with substance use disorders involved in legal matters, aiming to reduce recidivism and promote recovery. Collaboration between these fields is crucial in addressing the complex needs of justice-involved individuals struggling with addiction. Recent research at the nexus of Addiction Psychiatry and Criminal Justice has emphasized the effectiveness of diversion programs, specialized courts, and integrated treatment approaches in reducing the cycle of substance-related offenses. Studies have also highlighted the importance of early intervention and harm reduction strategies to enhance the overall well-being and rehabilitation of justice-involved individuals with addiction. Additionally, research explores the potential benefits of telehealth and digital tools in expanding access to addiction treatment within the criminal justice system. This session will delve into the interplay between Addiction Psychiatry and the Criminal Justice system, emphasizing collaborative treatment approaches.

• Track 18-1  Substance Use Disorders in the Criminal Justice System
• Track 18-2  Treatment in Correctional Facilities
• Track 18-3  Reentry and Recidivism Reduction
• Track 18-4  Ethical and Legal Considerations

Clinical Psychiatry is the branch of medicine that deals with the diagnosis, treatment, and prevention of mental illnesses, offering a holistic approach to understanding and addressing a wide range of psychological disorders. It plays a crucial role in improving the mental health and well-being of individuals, helping them lead more fulfilling lives. Recent research in Clinical Psychiatry has been marked by breakthroughs in the understanding of the neurobiological underpinnings of mental disorders and the development of targeted therapies, including novel medications and interventions. Additionally, studies have emphasized the value of telepsychiatry and digital mental health tools, expanding access to mental health care and enhancing the overall delivery of services, particularly during the global shift toward telehealth. This session will provide an in-depth exploration of Clinical Psychiatry, focusing on recent research findings and their practical applications in improving mental health treatment and care.

• Track 19-1  Clinical Psychiatry Diagnoses and Classification
• Track 19-2  Clinical Psychiatry Treatment Modalities
• Track 19-3  Clinical Psychiatry and Patient Care
• Track 19-4  Research and Advances in Clinical Psychiatry
• Track 19-5  Cultural Competence and Diversity in Clinical Psychiatry

Geriatric psychiatry is a specialized field of mental health care that concentrates on diagnosing, treating, and supporting the emotional and cognitive well-being of older adults. It addresses the unique mental health challenges, including dementia, depression, and anxiety, that often accompany the aging process and plays a vital role in promoting the quality of life for seniors. Recent research in Geriatric Psychiatry has emphasized the importance of early detection and intervention for age-related cognitive disorders such as Alzheimer's disease. Studies have also explored the benefits of non-pharmacological interventions like cognitive training and art therapy in promoting mental well-being among older adults. This session will provide a comprehensive exploration of Geriatric Psychiatry, focusing on the challenges and advancements in mental health care for older adults.

• Track 20-1  Geriatric Psychiatry Treatment Modalities
• Track 20-2  Geriatric Psychiatry and Cognitive Health
• Track 20-3  Geriatric Psychiatry and Long-Term Care
• Track 20-4  Geriatric Psychiatry and Family Support
• Track 20-5  Geriatric Psychiatry Evaluation

Forensic Psychiatry is a specialized branch of psychiatry that intersects with the legal system, involving the assessment, diagnosis, and treatment of individuals involved in legal matters. It plays a crucial role in evaluating mental health issues in legal contexts, such as criminal cases and civil litigation, and contributes to informed decisions within the justice system. Recent research in Forensic Psychiatry has highlighted the significance of accurate psychiatric assessments and risk evaluations in legal proceedings, promoting fair and just outcomes. Studies have also explored the use of advanced neuroimaging techniques to better understand the neurological basis of criminal behaviors and mental disorders. Additionally, research has delved into the impact of incarceration on mental health and the development of effective rehabilitation programs within correctional systems. This session will provide an extensive exploration of Forensic Psychiatry, focusing on the latest developments and practical insights in the field.

• Track 21-1  Forensic Psychiatry Evaluation
• Track 21-2  Criminal Responsibility and Insanity Defense
• Track 21-3  Violence Risk Management
• Track 21-4  Forensic Psychiatry in Legal Proceedings
• Track 21-5  Correctional Psychiatry and Inmate Mental Health

Psychiatric treatment encompasses a wide range of therapeutic interventions, including psychotherapy, medication management, and holistic approaches, tailored to address the unique mental health needs of individuals. It plays a vital role in improving the well-being and quality of life for those experiencing various psychological disorders. Recent research in psychiatric treatment has emphasized the efficacy of personalized treatment plans based on genetic and neurobiological markers, paving the way for precision psychiatry. Studies also explore the integration of digital mental health tools and telepsychiatry, offering accessible and convenient options for mental health care. Additionally, research has focused on innovative therapies, such as mindfulness-based interventions and neuromodulation techniques, to enhance the range of treatment options and improve outcomes for individuals with mental health conditions. This session will provide a thorough exploration of Psychiatric Treatment, concentrating on the latest developments and strategies to enhance mental health care.

• Track 22-1  Psychotherapy and Counseling
• Track 22-2  Medication Management
• Track 22-3  Inpatient and Outpatient Treatment
• Track 22-4  Rehabilitation and Recovery Programs
• Track 22-5  Crisis Intervention and Emergency Care

Psychiatric symptoms encompass a wide array of emotional, cognitive, and behavioral manifestations often associated with mental health disorders. These symptoms may include mood disturbances, anxiety, hallucinations, and impaired thinking, affecting an individual's psychological well-being and functioning. Recent research in psychiatric symptoms has focused on the neural underpinnings of symptom manifestation, using advanced neuroimaging techniques to better understand the brain's role in various mental health conditions. Additionally, studies have explored the potential of digital phenotyping and smartphone applications for real-time monitoring of psychiatric symptoms, offering innovative ways to track and manage mental health. This research has contributed to a more comprehensive and personalized approach to psychiatric care. This session will provide a comprehensive exploration of the intricate world of psychiatric symptoms, focusing on their understanding and effective management.

• Track 23-1  Mood Disturbances
• Track 23-2  Psychotic Symptoms
• Track 23-3  Anxiety and Stress-Related Symptoms
• Track 23-4  Cognitive and Behavioral Symptoms
• Track 23-5  Somatic and Dissociative Symptoms

Psychiatric disorders encompass a wide spectrum of mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders, which can significantly impact an individual's thoughts, emotions, and behaviors. Understanding and diagnosing these disorders is crucial for providing appropriate treatment and support to those affected. Recent research in Psychiatry Disorders has emphasized the importance of early intervention and personalized treatment strategies based on genetic, neurobiological, and environmental factors. Studies have also explored the role of digital mental health tools and telepsychiatry in increasing access to mental health care and improving patient engagement. Additionally, research has delved into the effectiveness of novel therapies, such as psychedelic-assisted treatments and neuromodulation techniques, in addressing various psychiatric conditions, offering new horizons for treatment options. This session will cover a comprehensive exploration of the field of Psychiatry Disorders, focusing on recent research findings and practical insights to enhance understanding and treatment.

• Track 24-1  Mood Disorders
• Track 24-2  Anxiety Disorders
• Track 24-3  Psychotic Disorders
• Track 24-4  Personality Disorders
• Track 24-5  Neurodevelopmental Disorders

Psychotherapy, also known as talk therapy, is a therapeutic approach that involves open and confidential conversations between a trained therapist and an individual or group. It aims to address emotional, behavioral, and mental health challenges by exploring thoughts, feelings, and behaviors, ultimately fostering personal growth and well-being. Recent research in psychotherapy has demonstrated the significant impact of therapeutic modalities like cognitive-behavioral therapy and dialectical behavior therapy on improving the lives of individuals with mental health challenges. Studies have also explored the potential of online psychotherapy and mobile applications for delivering effective mental health care, especially in remote or underserved areas. This session will comprehensively cover the field of Psychotherapy, delving into recent research findings and practical applications to enhance understanding and implementation in mental health care.

• Track 25-1  Cognitive-Behavioral Therapy (CBT)
• Track 25-2  Psychoanalytic and Psychodynamic Therapy
• Track 25-3  Humanistic and Person-Centered Therapy
• Track 25-4  Mindfulness-Based Therapy
• Track 25-5  Group Therapy and Family Therapy